Integral Diagnostics Limited (ASX:IDX)
1.620
-0.030 (-1.82%)
Nov 17, 2026, 11:20 AM AEDT
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 603.43 million as of November 16, 2026. It is the 15,558th most valuable company in the world and the 292nd biggest in Australia. Its market cap has decreased by 34.98% in one year.
Market Cap
603.43M
Enterprise Value
1.15B
Revenue
788.62M
Global Rank
Country Rank
#292 Australia
PE Ratio
27.93
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 603.43M, an increase of 128.77%. That is a compound annual growth rate of 7.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 603.43M | -36.26% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.83B |
| Australian Clinical Labs | 619.90M |
| Healius | 417.54M |
| Monash IVF Group | 292.23M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| Rhythm Biosciences | 23.36M |